# Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment

> **NCT06726122** · NA · ENROLLING_BY_INVITATION · sponsor: **Candela Corporation** · enrollment: 60 (estimated)

## Conditions studied

- Skin Laxity
- Wrinkle
- Skin Condition

## Interventions

- **DEVICE:** Profound Matrix

## Key facts

- **NCT ID:** NCT06726122
- **Lead sponsor:** Candela Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-28
- **Primary completion:** 2028-01
- **Final completion:** 2028-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06726122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06726122, "Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06726122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*